Fresenius Kabi USA, LLC is recalling approximately 2,199,850 vials of Famotidine Injection, USP (20 mg per 2 mL), a sterile medication used to treat stomach ulcers and acid reflux. The recall was initiated because testing showed the products contained endotoxin levels that exceeded safe limits, which indicates potential microbial contamination. Consumers who have this medication should contact their healthcare provider or pharmacist for guidance.
The product may contain bacterial endotoxins which, when injected, can cause serious inflammatory responses, including fever, chills, and life-threatening septic shock.
Quantity affected: 2,199,850 vials
Vial label for Famotidine Injection, USP 20 mg per 2 mL Lot: 6133194, 2 mL
Vial label for Famotidine Injection, USP 20 mg per 2 mL Lot: 6133388, 2 mL
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.